| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9AJP1
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
| GO:0006396 | RNA processing | 6 | 12 |
| GO:0006399 | tRNA metabolic process | 7 | 12 |
| GO:0006400 | tRNA modification | 6 | 12 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
| GO:0008033 | tRNA processing | 8 | 12 |
| GO:0008152 | metabolic process | 1 | 12 |
| GO:0009451 | RNA modification | 5 | 12 |
| GO:0009987 | cellular process | 1 | 12 |
| GO:0016070 | RNA metabolic process | 5 | 12 |
| GO:0034470 | ncRNA processing | 7 | 12 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
| GO:0034660 | ncRNA metabolic process | 6 | 12 |
| GO:0043170 | macromolecule metabolic process | 3 | 12 |
| GO:0043412 | macromolecule modification | 4 | 12 |
| GO:0044237 | cellular metabolic process | 2 | 12 |
| GO:0044238 | primary metabolic process | 2 | 12 |
| GO:0046483 | heterocycle metabolic process | 3 | 12 |
| GO:0071704 | organic substance metabolic process | 2 | 12 |
| GO:0090304 | nucleic acid metabolic process | 4 | 12 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
| GO:0001510 | RNA methylation | 4 | 1 |
| GO:0030488 | tRNA methylation | 5 | 1 |
| GO:0032259 | methylation | 2 | 3 |
| GO:0043414 | macromolecule methylation | 3 | 1 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 12 |
| GO:0016740 | transferase activity | 2 | 12 |
| GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 3 | 12 |
| GO:0102522 | tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity | 4 | 12 |
| GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
| GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
| GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
| GO:0008168 | methyltransferase activity | 4 | 3 |
| GO:0008173 | RNA methyltransferase activity | 4 | 1 |
| GO:0008175 | tRNA methyltransferase activity | 5 | 1 |
| GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 3 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.403 |
| CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.439 |
| CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.449 |
| CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.509 |
| CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.461 |
| CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.358 |
| CLV_PCSK_KEX2_1 | 254 | 256 | PF00082 | 0.284 |
| CLV_PCSK_KEX2_1 | 310 | 312 | PF00082 | 0.423 |
| CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.473 |
| CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.423 |
| CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.494 |
| CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.399 |
| CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.255 |
| CLV_PCSK_PC1ET2_1 | 254 | 256 | PF00082 | 0.329 |
| CLV_PCSK_PC1ET2_1 | 310 | 312 | PF00082 | 0.423 |
| CLV_PCSK_PC1ET2_1 | 99 | 101 | PF00082 | 0.529 |
| CLV_PCSK_PC7_1 | 88 | 94 | PF00082 | 0.509 |
| CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.254 |
| CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.329 |
| CLV_PCSK_SKI1_1 | 302 | 306 | PF00082 | 0.351 |
| CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.540 |
| CLV_Separin_Metazoa | 32 | 36 | PF03568 | 0.234 |
| DEG_APCC_DBOX_1 | 65 | 73 | PF00400 | 0.474 |
| DOC_MAPK_gen_1 | 65 | 73 | PF00069 | 0.501 |
| DOC_MAPK_MEF2A_6 | 65 | 73 | PF00069 | 0.501 |
| DOC_PP1_RVXF_1 | 138 | 144 | PF00149 | 0.438 |
| DOC_PP4_FxxP_1 | 174 | 177 | PF00568 | 0.443 |
| DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.524 |
| DOC_USP7_MATH_1 | 258 | 262 | PF00917 | 0.493 |
| DOC_USP7_UBL2_3 | 95 | 99 | PF12436 | 0.426 |
| DOC_WW_Pin1_4 | 118 | 123 | PF00397 | 0.426 |
| DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.296 |
| LIG_14-3-3_CanoR_1 | 117 | 124 | PF00244 | 0.482 |
| LIG_14-3-3_CanoR_1 | 248 | 253 | PF00244 | 0.443 |
| LIG_14-3-3_CanoR_1 | 297 | 304 | PF00244 | 0.379 |
| LIG_14-3-3_CanoR_1 | 87 | 91 | PF00244 | 0.470 |
| LIG_14-3-3_CanoR_1 | 98 | 103 | PF00244 | 0.285 |
| LIG_Actin_WH2_2 | 193 | 209 | PF00022 | 0.493 |
| LIG_Actin_WH2_2 | 267 | 284 | PF00022 | 0.509 |
| LIG_Actin_WH2_2 | 289 | 304 | PF00022 | 0.457 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.285 |
| LIG_BRCT_BRCA1_1 | 120 | 124 | PF00533 | 0.408 |
| LIG_BRCT_BRCA1_1 | 195 | 199 | PF00533 | 0.468 |
| LIG_BRCT_BRCA1_2 | 195 | 201 | PF00533 | 0.468 |
| LIG_Clathr_ClatBox_1 | 54 | 58 | PF01394 | 0.466 |
| LIG_DLG_GKlike_1 | 65 | 72 | PF00625 | 0.502 |
| LIG_EH1_1 | 312 | 320 | PF00400 | 0.378 |
| LIG_FHA_1 | 123 | 129 | PF00498 | 0.451 |
| LIG_FHA_1 | 173 | 179 | PF00498 | 0.438 |
| LIG_FHA_2 | 156 | 162 | PF00498 | 0.548 |
| LIG_FHA_2 | 27 | 33 | PF00498 | 0.476 |
| LIG_LIR_Gen_1 | 196 | 206 | PF02991 | 0.484 |
| LIG_LIR_Gen_1 | 290 | 298 | PF02991 | 0.228 |
| LIG_LIR_Nem_3 | 166 | 171 | PF02991 | 0.435 |
| LIG_LIR_Nem_3 | 196 | 202 | PF02991 | 0.443 |
| LIG_LIR_Nem_3 | 290 | 295 | PF02991 | 0.341 |
| LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.427 |
| LIG_Pex14_2 | 10 | 14 | PF04695 | 0.392 |
| LIG_Pex14_2 | 41 | 45 | PF04695 | 0.376 |
| LIG_SH2_CRK | 267 | 271 | PF00017 | 0.324 |
| LIG_SH2_STAP1 | 134 | 138 | PF00017 | 0.472 |
| LIG_SH2_STAP1 | 82 | 86 | PF00017 | 0.494 |
| LIG_SH2_STAT5 | 173 | 176 | PF00017 | 0.443 |
| LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.439 |
| LIG_SUMO_SIM_anti_2 | 51 | 56 | PF11976 | 0.290 |
| LIG_SUMO_SIM_par_1 | 46 | 51 | PF11976 | 0.407 |
| LIG_SUMO_SIM_par_1 | 53 | 58 | PF11976 | 0.338 |
| LIG_TRAF2_1 | 276 | 279 | PF00917 | 0.438 |
| LIG_TYR_ITIM | 171 | 176 | PF00017 | 0.296 |
| LIG_TYR_ITIM | 265 | 270 | PF00017 | 0.325 |
| LIG_WRC_WIRS_1 | 133 | 138 | PF05994 | 0.416 |
| MOD_CK1_1 | 101 | 107 | PF00069 | 0.472 |
| MOD_CK1_1 | 145 | 151 | PF00069 | 0.365 |
| MOD_CK2_1 | 26 | 32 | PF00069 | 0.505 |
| MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.293 |
| MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.296 |
| MOD_GlcNHglycan | 261 | 264 | PF01048 | 0.429 |
| MOD_GSK3_1 | 116 | 123 | PF00069 | 0.347 |
| MOD_GSK3_1 | 132 | 139 | PF00069 | 0.276 |
| MOD_GSK3_1 | 141 | 148 | PF00069 | 0.112 |
| MOD_GSK3_1 | 77 | 84 | PF00069 | 0.481 |
| MOD_N-GLC_1 | 146 | 151 | PF02516 | 0.296 |
| MOD_NEK2_1 | 111 | 116 | PF00069 | 0.442 |
| MOD_NEK2_1 | 136 | 141 | PF00069 | 0.363 |
| MOD_NEK2_1 | 142 | 147 | PF00069 | 0.172 |
| MOD_NEK2_1 | 41 | 46 | PF00069 | 0.367 |
| MOD_NEK2_1 | 86 | 91 | PF00069 | 0.452 |
| MOD_NEK2_2 | 82 | 87 | PF00069 | 0.428 |
| MOD_PIKK_1 | 98 | 104 | PF00454 | 0.273 |
| MOD_PKA_1 | 65 | 71 | PF00069 | 0.479 |
| MOD_PKA_1 | 98 | 104 | PF00069 | 0.425 |
| MOD_PKA_2 | 116 | 122 | PF00069 | 0.518 |
| MOD_PKA_2 | 259 | 265 | PF00069 | 0.431 |
| MOD_PKA_2 | 296 | 302 | PF00069 | 0.488 |
| MOD_PKA_2 | 65 | 71 | PF00069 | 0.475 |
| MOD_PKA_2 | 86 | 92 | PF00069 | 0.462 |
| MOD_Plk_1 | 111 | 117 | PF00069 | 0.521 |
| MOD_Plk_1 | 136 | 142 | PF00069 | 0.399 |
| MOD_Plk_2-3 | 27 | 33 | PF00069 | 0.508 |
| MOD_Plk_4 | 241 | 247 | PF00069 | 0.339 |
| MOD_Plk_4 | 248 | 254 | PF00069 | 0.276 |
| MOD_ProDKin_1 | 118 | 124 | PF00069 | 0.420 |
| MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.298 |
| TRG_DiLeu_BaEn_3 | 290 | 296 | PF01217 | 0.446 |
| TRG_ENDOCYTIC_2 | 173 | 176 | PF00928 | 0.296 |
| TRG_ENDOCYTIC_2 | 267 | 270 | PF00928 | 0.320 |
| TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.480 |
| TRG_ER_diArg_1 | 7 | 9 | PF00400 | 0.422 |
| TRG_ER_diArg_1 | 86 | 88 | PF00400 | 0.507 |
| TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.517 |
| TRG_NLS_Bipartite_1 | 87 | 102 | PF00514 | 0.467 |
| TRG_NLS_MonoExtN_4 | 95 | 102 | PF00514 | 0.267 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P4L5 | Leptomonas seymouri | 70% | 80% |
| A0A0S4JHI6 | Bodo saltans | 49% | 78% |
| A0A1X0P9M7 | Trypanosomatidae | 56% | 78% |
| A0A422N7F4 | Trypanosoma rangeli | 55% | 82% |
| A0A451EJL2 | Leishmania donovani | 93% | 82% |
| A4H3H8 | Leishmania braziliensis | 88% | 100% |
| D0A212 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 81% |
| E9ACF3 | Leishmania major | 94% | 100% |
| E9AG25 | Leishmania infantum | 93% | 82% |
| Q0P466 | Danio rerio | 33% | 79% |
| V5B8P6 | Trypanosoma cruzi | 55% | 82% |